DAM
BMY icon

Draper Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Draper Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,700
Closed -$161 – 37
2023
Q3 		$161 Buy
+24,700
New +$1.51M ﹤0.01% 37

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Draper Asset Management's BMY Position: Q2 2024 in Review

Draper Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 6,999 shares — an estimated $371K sold.

Draper Asset Management first reported a position in BMY in Q1 2022 and held it in 5 quarters. The position peaked at $986K in Q2 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Draper Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Draper Asset Management sold 6,999 Bristol-Myers Squibb shares in Q2 2024, an estimated $371K.
  • Draper Asset Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 5 quarters.
  • Draper Asset Management's Bristol-Myers Squibb position peaked at $986K in Q2 2022.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Draper Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.